Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Martindale Pharma CEO takes up new role with parent company Ethypharm

Martindale Pharma CEO takes up new role with parent company Ethypharm

31st May 2017

Martindale Pharma has announced that its chief executive officer Michael Harris is taking up a position as chief operating officer of the Ethypharm group.

Ethypharm, which acquired Martindale in February, has appointed Mr Harris to the broader role to take responsibility for its sales, quality, manufacturing and industrial teams.

He can boast more than 20 years in pharmaceutical and life science industry roles, having held senior managerial positions at a number of major international life science and healthcare companies including GE Healthcare and Sigma-Aldrich.

Hugues Lecat, chief executive officer of Ethypharm, said: "His experience and knowledge in the pharmaceutical and life sciences industry will lead us to shape Ethypharm into a European leading specialty pharmaceuticals company that is providing patients with access to differentiated and affordable medicines."

Ethypharm has described the acquisition of Martindale Pharma as a key element in its European growth strategy, with its portfolio set to focus on treatments for pain, addiction and critical care.

With over 20 years of experience within the consumer market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current consumer roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801836416-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.